Cristofanilli CTC Laboratory
@CtcLaboratory
The lab of Dr. Massimo Cristofanilli studies cancer cells & tumor DNA isolated from the peripheral blood of patients with solid tumors (breast, prostate, lung).
ID:1337434727943442432
11-12-2020 16:33:50
382 Tweets
398 Followers
189 Following
That’s a wrap! It’s been an inspiring time at Focus on TOP #FTOP24 !
Thanks to our amazing faculty and to everyone who joined us, see you next year!
Fabio Puglisi Massimo Cristofanilli, MD, FACP Umberto Malapelle Maria Vittoria Dieci Luca Malorni Gustavo Baldassarre Rossana Roncato Marzia Del Re, PharmD, PhD
#Oncology #liquidbiopsy
🚨🔔ISLB 2024 - Save The Date! 23-25 November 2024 in Denver Colorado!. 🏔️🌆Subscribe for the newsletter and prepare your abstracts!! M JOSE SERRANO (LB&Cancer Interception group) Umberto Malapelle David Gandara Massimo Cristofanilli, MD, FACP ELO 2024.islb.info
Our next #PrecisionMedicine Research Conference, 'Discussion of Clinical #WGS and Research Whole Exome and #RNASeq ,' will be presented by Dr. Daniela Guevara, Fellow in Medicine WCM Englander Institute for Precision Medicine, with patients referred by Cora Sternberg and Massimo Cristofanilli, MD, FACP!
Feb. 22 at 1 PM via Zoom
Dr. Eleni Andreopoulou (Eleni Andreopoulou, MD) spoke with Greek news outlet mononewsgr about #BreastCancer #research , treatment, screening, the aims of #PrecisionMedicine , and her personal perspective as a female physician: bit.ly/4bAZOAg (cc: WCM Englander Institute for Precision Medicine)
Circulating Tumor Cells Prediction in Hormone Receptor Positive HER2-Negative Advanced Breast Cancer: A Retrospective Analysis of the MONARCH 2 Trial academic.oup.com/oncolo/article… Cristofanilli CTC Laboratory WCM Englander Institute for Precision Medicine WCM Englander Institute for Precision Medicine #MBC
Please join us to celebrate 20 years of liquid biopsy history: research, clinical applications and change in practice. WCM Englander Institute for Precision Medicine Massimo Cristofanilli, MD, FACP Weill Cornell Medicine Meyer Cancer Center Cristofanilli CTC Laboratory Christian Rolfo M JOSE SERRANO (LB&Cancer Interception group)
The WCM Englander Institute for Precision Medicine Scientific Director Dr. Massimo Cristofanilli (@MCristofanill) will present a Weill Cornell Medicine Physician Scientist Seminar Series lecture, 'Liquid biopsy in #breastcancer : Can we use the patient as a new translational model?'
Wednesday at noon via Zoom.
Cellular residual disease (CRD) in early breast cancer –Expanding the concept of minimal residual disease monitoring? - ScienceDirect WCM Englander Institute for Precision Medicine Weill Cornell Medicine Meyer Cancer Center Cristofanilli CTC Laboratory International Society of Liquid Biopsy sciencedirect.com/science/articl…
The landscape of targeted therapies in HR+ MBC is expanding with more opportunities for patients. Treatment selection now will be based on molecular and safety profile. #mbc International Society of Liquid Biopsy Weill Cornell Medicine Meyer Cancer Center Weill Cornell Medicine Cristofanilli CTC Laboratory #ctdna
'Growing is never-ending. As long as you keep learning & evolving you will never stop growing!'
#ctDNA #CTCs #LiquidBiopsy
Carolina Reduzzi Jeannine Donahue Eleonora Nicolò Letizia Pontolillo Nadia Bayou Laura Sofia Munoz Arcos Massimo Cristofanilli, MD, FACP Weill Cornell Breast Center WCM Englander Institute for Precision Medicine
It was a great honor to have been introduced by Professor Massimo Cristofanilli, MD, FACP in this important milestone of my life. Thanks to him and Professor Bria for the mentoring.
Cristofanilli CTC Laboratory Università Cattolica Weill Cornell Breast Center
#HappyHalloween from The Cristofanilli’s CTC Laboratory #LiquidBiopsy #CTCs #ctDNA #PrecisionMedicine #TranslationalResearch #BenchToBesideCare Weill Cornell Breast Center
Critical role of CTCs in metastatic progression and chemotherapy resistance Cristofanilli CTC Laboratory WCM Englander Institute for Precision Medicine Weill Cornell Medicine Meyer Cancer Center
The WCM Englander Institute for Precision Medicine's Scientific Director Dr. Massimo Cristofanilli (@MCristofanill) talked with Spectrum News NY1 News about the use of #liquidbiopsy in detecting and treating #BreastCancer as early as possible. #BreastCancer AwarenessMonth
muckrack.com/broadcast/save…
A strong WCM Breast Cancer Clinical program and Meyer Cancer Center Leadership at the BCRF event in NY. Weill Cornell Medicine Meyer Cancer Center Weill Cornell Breast Center NewYork-Presbyterian Taha WCM Englander Institute for Precision Medicine Weill Cornell Medicine
Real-time assessment of HER2 status in circulating tumor cells of brea... sciencedirect.com/science/articl…
WCM Englander Institute for Precision Medicine International Society of Liquid Biopsy Weill Cornell Medicine Meyer Cancer Center Cristofanilli CTC Laboratory